הבדלים בין גרסאות בדף "קוד ATC code - ATC"
מתוך ויקירפואה
שורה 1,065: | שורה 1,065: | ||
| | | | ||
|[[Antivirals for systemic use]] | |[[Antivirals for systemic use]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | |J05A | ||
+ | | | ||
+ | | | ||
+ | |[[Direct acting antiviral drugs]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AA | ||
+ | | | ||
+ | |[[Thiosemicarbazones]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AB | ||
+ | | | ||
+ | |[[Nucleosides and nucleotides excluding reverse transcriptase inhibitors]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AC | ||
+ | | | ||
+ | |[[Cyclic amines]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AD | ||
+ | | | ||
+ | |[[Phosphonic acid derivatives]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AE | ||
+ | | | ||
+ | |[[Protease inhibitors]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AF | ||
+ | | | ||
+ | |[[Nucleoside and nucleotide reverse transcriptase inhibitors]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AG | ||
+ | | | ||
+ | |[[Non-nucleoside reverse transcriptase inhibitors]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AH | ||
+ | | | ||
+ | |[[Neuraminidase inhibitors]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AR | ||
+ | | | ||
+ | |[[Antivirals for treatment of HIV infections, combinations]] | ||
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |J05AX | ||
+ | | | ||
+ | |[[Other antivirals]] | ||
|- | |- | ||
| | | |
גרסה מ־08:39, 1 באוגוסט 2013
מפתח קודי ATC